[Pneumococcal infection among community-acquired pneumonia. A retrospective study of 230 hospitalized children]

M-H Odièvre1, E Sanni, F de Broucker

  • 1Service de pédiatrie, hôpital Louis-Mourier, Assistance publique-Hôpitaux de Paris, 178, rue des Renouillers, 92700 Colombes, France. marie-helene.odievre@lmr.aphp.fr

Insights

This study suggests specific clinical criteria can help identify pneumococcal pneumonia in children. Early immunization against pneumococcus is recommended to reduce infection rates.

Area of Science:

  • Pediatric Infectious Diseases
  • Bacteriology

Context:

  • Community-acquired pneumonia (CAP) is a common childhood illness.
  • Determining the specific causative agent, particularly Streptococcus pneumoniae, can be challenging.
  • Accurate diagnosis is crucial for effective treatment and public health strategies.

Purpose:

  • To identify clinical and biological arguments supporting pneumococcal origin in pediatric CAP.
  • To evaluate the utility of specific criteria in diagnosing pneumococcal infections.
  • To inform early therapeutic decisions and preventative measures.

Summary:

  • A retrospective analysis of 230 children with CAP was conducted, categorizing them into confirmed (positive blood culture), probable (biological markers), and possible pneumococcal infection groups.
  • Children with confirmed pneumococcal pneumonia (n=7) exhibited high fever (>39°C) and elevated white blood cell counts, neutrophil counts, or C-reactive protein levels.
  • Chest X-rays were not definitive, and prior antibiotic use complicated definitive diagnosis in probable and possible groups.

Impact:

  • Findings suggest specific criteria can aid in selecting appropriate initial antibiotic therapy for suspected pneumococcal pneumonia.
  • Highlights the importance of early pneumococcal immunization to decrease the incidence of this infection.
  • Contributes to improved diagnostic and management strategies for pediatric CAP.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: